期刊文献+

P300/CBP相关因子在肝细胞癌中的表达及临床意义

Expression of P300/CBP-associated factor in hepatocellular carcinoma and its clinicopathological significance
下载PDF
导出
摘要 目的:检测P300/CBP相关因子(P300/CBP-associated factor,PCAF)在肝细胞癌(hepatocellular carcinoma,HCC)中的表达情况,分析其与肝癌临床病理特征之间的相关性。方法:收集40例HCC及对应癌旁组织,运用RT-PCR、免疫组化技术检测PCAF在肝癌及对应癌旁组织中的表达情况,研究PCAF蛋白表达与肝癌临床病理特征之间的相关性;应用Western blot技术检测人正常肝细胞LO2和肝癌细胞HepG2和SMMC-7721中PCAF蛋白的表达。结果:PCAF mRNA及蛋白在肝癌组织中的表达低于对应的癌旁组织(P=0.000);PCAF蛋白低表达与肿瘤肝内转移(r s=0.413,P=0.037)、门脉侵犯(r s=0.589,P=0.011)和高TNM分期(r s=0.513,P=0.029)相关;人肝癌细胞株HepG2和SMMC-7721中PCAF蛋白的表达较正常肝细胞株LO2降低(P=0.000)。结论:肝癌细胞系及肝癌组织中PCAF表达下调,且PCAF的表达下调与肝癌的恶性病理特征相关。 Objective :To investigate the expression of P300/CBP-associated factor(PCAF) and its correlation with the clinicopatholog- ical features in hepatocellular carcinoma(HCC). Methods:Forty samples of surgically resected HCC and adjacent noncancerous tis- sues were collected. PCAF expression in the samples was detected using RT-PCR and immunohistochemical staining. Correlation be- tween PCAF protein expression and clinicopathological feature was analyzed. PCAF protein expression in normal hepatic cell line (LO2) and HCC cell lines(HepG2 and SMMC-7721 ) was detected. Results:mRNA and protein expression of PCAF in HCC tissues was significantly down-regulated compared with that of adjacent noncancerous tissues(P〈O.OS,respectively). Clinicopathological analysis suggested that PCAF protein low-expression was associated with tumor intrahepatic metastasis(rs=O.413,P=0.037),portal vein invasion (rs=0.589, P=O.011 ) and advanced TNM stage (re=0.513, P=0.029). Expression of PCAF protein in HCC cell lines HepG2 and SMMC-7721 was significandy lower compared with that in hepatic cell line LO2(P〈0.05,respectively). Conclusions:Expression of PCAF is down-regulated in HCC cell lines and HCC tissues and the low-expression of PCAF is correlated with poor clinieo- pathological characteristics of HCC.
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2013年第11期1348-1351,共4页 Journal of Chongqing Medical University
关键词 P300 CBP相关因子 肝细胞癌 组蛋白乙酰化 临床意义 P300/CBP-associated factor hepatocellular carcinoma histone acetylation clinical significance
  • 相关文献

参考文献16

  • 1涂康生,杨雪,宋涛,郭成,杨威,刘青光.原发性肝细胞癌组织中CIP2A和c-myc蛋白的表达及其意义[J].中国普通外科杂志,2011,20(1):95-98. 被引量:17
  • 2周振宇,涂康生,张竞,郑鑫,高洁,姚英民,刘青光.Fbxw7在肝癌中的表达及与肝癌细胞增殖相关性研究[J].细胞与分子免疫学杂志,2012,28(12):1303-1306. 被引量:26
  • 3Zhu CsQin Y R,Xie D,et al.Characterization of tumor suppressivefunction of P300/CBP-associated factor at frequently deleted region3p24 in esophageal squamous cell carcinoma[J].Oncogene,2009,28(31):2821-2828.
  • 4Ying M ZtWang J J,Li D W,et al.The p300/CBP associated fac-tor: is frequently downregulated in intestinal-type gastric carcinoma andconstitutes a biomarker for clinical outcome[J].Cancer Biol Ther,2010,9(4):312-320.
  • 5Akil A,Ezzikouri S,E1 F A,et al.Associations of genetic variants inthe transcriptional coactivators EP300 and PCAF with hepatocellularcarcinoma[J].Cancer Epidemiol,2012,36(5):300-305.
  • 6Tu K,Zheng X,Zan X,et al.Evaluation of Fbxw7 expression and itscorrelation with the expression of c-Myc,cyclin E and p53 in humanhepatocellular carcinoma[J].Hepatol Res,2012,42(9):904-910.
  • 7Yang X J,Ogryzko V V,Nishikawa J,et al.A p300/CBP-associatedfactor that competes with the adenoviral oncoprotein EI A[J].Nature,1996,382(6589);319-324.
  • 8Ozdag H,Batley S J,Forsti A,et al.Mutation analysis of CBP andPCAF reveals rare inactivating mutations in cancer cell lines but not inprimary tumours[J].Br J Cancer,2002,487(10): 1162-1165.
  • 9Poux A N,Marmorstein R.Molecular basis for Gcn5/PCAF histoneacetyltransferase selectivity for histone and nonhistone substrates[J].Biochemistry,2003,42(49): 14366-14374.
  • 10Eckner R.p53-dependent growth arrest and induction of p21 j acritical role for PCAF-mediated histone acetylation[J].Cell Cycle,2012,ll(14):2591-2592.

二级参考文献33

共引文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部